Frequently Asked Questions

Where can I access policies related to viral hepatitis in prisons? 

Healthcare providers seeking information on national, regional, or local policies regarding viral hepatitis in prisons in Europe can access valuable resources through various channels. Organisations including ECDC, EUDA, and WHO all provide guidance and the latest evidence base.

National health departments or ministries of health typically publish and update guidelines and policies on infectious diseases, including viral hepatitis, and often have dedicated sections for correctional facilities.  

​​​​​​​Additionally, healthcare providers can refer to regional health authorities, which, depending on the organisation of the country, may offer overarching guidelines or support within the individual countries.  

At the local level, prison health services or public health agencies within individual countries often provide detailed information on protocols, screening procedures, and treatment guidelines specific to the prison setting. ​​​​​​ 

Collaboration with professional associations such as the European Association for the Study of the Liver (EASL), research institutions, or non-governmental organisations focused on infectious diseases and the health of people living in prison may also yield valuable insights and resources.  

Why is the collection of data relating to hepatitis elimination within prisons important? 

Effective and well planned data management ​​​​within prisons is critical for the successful development of any strategy related to viral hepatitis. Through the systematic collection and analysis of data, such systems can enable a clear assessment of health needs through the monitoring of hepatitis infections and the identification of high-risk groups and associated health issues, and when combined with information on gaps in services can enable the development of tailored prevention and treatment strategies. ​​(For further information, see Section 4: Monitoring and Evaluation). 

How can healthcare providers ensure continuity of care for individuals between prison and community settings? 

Ensuring continuity of care for individuals transitioning between the prison and community settings involves establishing robust communication channels between prison healthcare providers and external healthcare entities.  

This includes sharing comprehensive medical records, treatment plans, and conducting joint care coordination efforts. Standardising protocols for the transfer of healthcare responsibilities, engaging in collaborative discharge planning, and providing individuals with medications upon release are integral components.  

Healthcare providers should engage in training programs to enhance their skills in navigating the complex dynamics of transitioning healthcare across these environments. 

How can healthcare providers in prison collaborate with external agencies, to maximise the impact of viral hepatitis programs? 

Effective communication underpins the successful collaboration across different organisations and groups that is needed to ensure the effective development of services in the prison.  

Good communications are particularly important in the context of prison health services, with services delivered across the prison and community. Collaborating with external entities involves establishing robust partnerships with community healthcare providers, public health agencies, and NGOs.  

Formalising agreements for information exchange and coordinated care is essential. Engaging in joint initiatives, such as outreach programs and community-based testing, strengthens the overall impact of viral hepatitis programs.  

Healthcare providers should actively participate in inter-agency committees, advocacy groups, and regional networks to foster collaboration, share resources, and contribute to a more cohesive and effective response to viral hepatitis in both prison and community settings.